We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$17B
AUM Growth
-$1.5B
Cap. Flow
-$3.24B
Cap. Flow %
-19.02%
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 27.35%
2 Financials 13.45%
3 Industrials 10.46%
4 Healthcare 10.18%
5 Communication Services 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIC icon
2126
Global Industrial
GIC
$1.49B
$222K ﹤0.01%
8,215
EVEX icon
2127
Eve Holding
EVEX
$976M
$222K ﹤0.01%
32,307
+6,392
+25% +$28.5K
ETSY icon
2128
Etsy
ETSY
$7.4B
$221K ﹤0.01%
4,414
-755
-15% -$37.6K
ETON icon
2129
Eton Pharmaceutcials
ETON
$1.12B
$221K ﹤0.01%
+15,537
New +$246K
CAPR icon
2130
Capricor Therapeutics
CAPR
$244M
$221K ﹤0.01%
22,242
NESR
2131
National Energy Services Reunited Corp
NESR
$3.62B
$221K ﹤0.01%
+36,645
New +$227K
NXDR
2132
Nextdoor Holdings
NXDR
$998M
$220K ﹤0.01%
132,681
+64,571
+95% +$97.4K
TLN
2133
Talen Energy Corp
TLN
$17.2B
$220K ﹤0.01%
+756
New +$179K
CTEV
2134
Claritev Corp
CTEV
$716M
$218K ﹤0.01%
+4,835
New +$139K
BKV
2135
BKV Corp
BKV
$2.84B
$218K ﹤0.01%
9,034
+179
+2% +$3.7K
LAB icon
2136
Standard BioTools
LAB
$294M
$218K ﹤0.01%
181,262
+60,285
+50% +$66.8K
DIN icon
2137
Dine Brands
DIN
$440M
$217K ﹤0.01%
8,919
ZIP icon
2138
ZipRecruiter
ZIP
$388M
$217K ﹤0.01%
43,286
TRML
2139
DELISTED
Tourmaline Bio
TRML
$217K ﹤0.01%
13,553
KELYA icon
2140
Kelly Services Class A
KELYA
$566M
$216K ﹤0.01%
18,459
-168
-0.9% -$1.98K
RGNX icon
2141
Regenxbio
RGNX
$704M
$215K ﹤0.01%
26,240
+2,694
+11% +$22.6K
ANGO icon
2142
AngioDynamics
ANGO
$647M
$214K ﹤0.01%
21,609
TALK icon
2143
Talkspace
TALK
$871M
$214K ﹤0.01%
76,999
+25,178
+49% +$74.2K
BBBY
2144
Bed Bath & Beyond
BBBY
$423M
$214K ﹤0.01%
34,155
+5,768
+20% +$27.9K
QXO
2145
QXO Inc
QXO
$16.1B
$214K ﹤0.01%
+9,914
New +$163K
OM icon
2146
Outset Medical
OM
$79.9M
$213K ﹤0.01%
+11,074
New +$173K
LOAR icon
2147
Loar Holdings
LOAR
$6.93B
$212K ﹤0.01%
2,465
+451
+22% +$39K
ARCT icon
2148
Arcturus Therapeutics
ARCT
$223M
$212K ﹤0.01%
16,295
SLDP icon
2149
Solid Power
SLDP
$545M
$212K ﹤0.01%
96,750
+23,566
+32% +$33.1K
KODK icon
2150
Kodak
KODK
$978M
$212K ﹤0.01%
37,491
+7,612
+25% +$45.8K

Similar funds

MetLife Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.

  • MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
  • MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
  • MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
  • MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
  • MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
  • MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.

Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.